Tenglow-20 Tablet contains ???????Teneligliptin????????, which belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors used to treat type 2 diabetes when diet and exercise alone cannot control their blood sugar levels. It works by blocking the action of DPP-4 (an enzyme that destroys the hormone ???????Incretin????????). The enzyme ???????Incretins???????? helps produce more insulin only when required and reduces the liver's blood sugar level when not needed. Tenglow-20 Tablet should not be used in patients with type 1 diabetes and for the treatment of diabetic ketoacidosis. Thus, Tenglow-20 Tablet plays a vital role in controlling blood sugar levels and prevents serious complications of diabetes like eyesight loss (retinopathy), kidney (nephropathy), nerve damage (neuropathy), diabetic foot ulcer, and delayed wound healing.